Cell environment influences type of liver tumor

September 13, 2018, Universitaet Tübingen
Cancer cell during cell division. Credit: National Institutes of Health

Liver cancer is the second leading cause of cancer death worldwide. Two forms of primary liver cancer cover the majority of cases: About 10 to 20 percent of those affected develop a bile duct carcinoma within the liver (intrahepatic cholangiocellular carcinoma; ICC), the far higher proportion of liver cancers are hepatocellular carcinomas (HCC). In recent years, in particular, the number of patients with the highly invasive intrahepatic cholangiocellular carcinomas increased noticeably, although both tumor types show overlaps regarding their risk factors. A team of researchers led by Prof. Lars Zender from the University Hospital Tübingen and German Cancer Consortium (DKTK) now elegantly demonstrated that the surrounding cellular environment with its dying liver cells determines the path taken by tumor cells. The results will be published in the prestigious journal Nature on September 12, 2018.

While progress in early detection and treatment has led to a reduction in mortality for many other types of cancer, there has been a dramatic increase in mortality among patients who have cancer within the liver. Especially fatty liver, which is becoming increasingly common in western countries, now leads to chronically pre-damaged livers in many patients, which are a risk factor for . Strikingly, patients with the same predisposition or liver damaging risk factors either develop or intrahepatic cholangiocellular carcinoma.

Both cancers are different regarding their behavior and are also treated differently.

The microenvironment of cancer cells, and in particular, the special form of cell death occuring in this environment, proved to be decisive for the development of the respective type of cancer. The scientists showed that precursors of cancer cells in whose environment cells died by apoptosis, the classical cell death, developed into hepatocellular carcinoma. Precancerous cells, in whose environment cells died due to necroptosis, led to intrahepatic cholangiocellular carcinoma. In necroptosis, the cell membrane dissolves, and the cell content causes inflammation in the environment of the cancer cell, while in classical programmed cell death small vesicles are formed which are eliminated by the immune system.

The results could be verified both in mouse models and in human tissue samples. Cancer researcher Xin Wei Wang from the Laboratory of Human Carcinogenesis (Center for Cancer Research, National Cancer Institute, Bethesda, USA) contributed crucial human analysis data, and Oliver Bischof, a distinguished epigeneticists from the Institut Pasteur (Laboratory of Nuclear Organization and Oncogenesis) in Paris, unraveled how the microenvironment affects gene regulation in the cancer cell.

What do the findings mean for clinical practice? "Future research will have to investigate whether the direct cell environment affects not only the type of tumor development but also the therapy," says Professor Lars Zender. In the treatment of HCC with chemoembolization, it has already been observed that a part of the original liver cancer can turn into a bile duct . This could be a reason why the cancer no longer responds to the original therapy. "We may be on the trail of a therapy resistance mechanism for cancer," explains the renowned oncologist and "we hope that the findings will inform novel therapeutic options in the future."

Explore further: Researchers discover new anti-cancer protein

More information: Marco Seehawer et al. Necroptosis microenvironment directs lineage commitment in liver cancer, Nature (2018). DOI: 10.1038/s41586-018-0519-y

Related Stories

Researchers discover new anti-cancer protein

March 21, 2018
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Metabolic syndrome may increase risk for liver cancer

April 3, 2011
Scientists have confirmed that metabolic syndrome, a constellation of conditions that increases the risk of heart disease and diabetes, may also increase the risk of the two most common types of liver cancer, according to ...

Hot on the trail of the hepatitis-liver cancer connection

January 30, 2015
Using whole genomic sequencing, scientists from RIKEN in Japan have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of ...

New receptor genes turn T-cells into powerful liver cancer foes

April 3, 2018
Mouse genes that make human T cells powerful at fighting liver cancer could one day help patients do the same, scientists report.

New DNA testing for liver cancer could improve survival

September 10, 2015
Detection of small fragments of tumor DNA, known as circulating tumor DNA, in a patient's pre-surgery serum samples predicts early recurrence of hepatocellular carcinoma and may guide treatment, according to a study published ...

Recommended for you

Researchers identify a mechanism that fuels cancer cells' growth

November 14, 2018
Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified sodium glucose transporter 2, or SGLT2, as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes ...

A new approach to detecting cancer earlier from blood tests: study

November 14, 2018
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined "liquid biopsy", epigenetic alterations and machine learning to develop a blood test to detect and classify ...

New antibody breakthrough to lead the fight against cancer

November 14, 2018
Scientists at the University of Southampton have developed a new antibody that could hold the key to unlocking cancer's defence against the body's immune system.

Photoacoustic imaging may help doctors detect ovarian tumors earlier

November 14, 2018
Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University in St. Louis has found an innovative way to use sound ...

Solving the mystery of NPM1 in acute myeloid leukemia

November 13, 2018
Although it has long been recognized that mutations of gene NPM1 play an important role in acute myeloid leukemia, no one has determined how the normal and the mutated forms of the protein NPM1 function.

Cognitive decline—radiation—brain tumor prevented by temporarily shutting down immune response

November 13, 2018
Treating brain tumors comes at a steep cost, especially for children. More than half of patients who endure radiation therapy for these tumors experience irreversible cognitive decline, a side-effect that has particularly ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.